Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Premier Investments (PMV.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-03-3028.6831.00Buy
2022-06-2319.7623.00Buy
2022-09-2923.6926.00Buy
2023-02-2427.32-No Rating
2023-02-2827.3426.00Buy
2023-03-2225.8026.00Neutral
2023-06-2021.0320.00Sell
2023-08-2124.4123.00Sell
2023-09-2925.0023.50Sell
2023-12-0125.1124.00Sell
2024-03-2130.4027.00Sell
2024-03-2731.0731.00Neutral
2024-09-0933.8533.00Neutral
2024-09-2530.6131.00Neutral
2025-01-1327.7830.00Neutral
2025-03-1920.7524.00Buy

Disclosures

  • UBS Securities Australia Limited is acting as advisor to Premier Investments Ltd on a strategic review, including the potential demergers of Smiggle and Peter Alexander, and will receive a fee for acting in this capacity.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.